GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ahn-Gook Pharmaceutical Co Ltd (XKRX:001540) » Definitions » Change In Receivables

Ahn-Gook Pharmaceutical Co (XKRX:001540) Change In Receivables : ₩3,541 Mil (TTM As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Ahn-Gook Pharmaceutical Co Change In Receivables?

Ahn-Gook Pharmaceutical Co's change in receivables for the quarter that ended in Dec. 2024 was ₩-875 Mil. It means Ahn-Gook Pharmaceutical Co's Accounts Receivable increased by ₩875 Mil from Sep. 2024 to Dec. 2024 .

Ahn-Gook Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2024 was ₩3,541 Mil. It means Ahn-Gook Pharmaceutical Co's Accounts Receivable declined by ₩3,541 Mil from Dec. 2023 to Dec. 2024 .

Ahn-Gook Pharmaceutical Co's Accounts Receivable for the quarter that ended in Dec. 2024 was ₩58,722 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Ahn-Gook Pharmaceutical Co's Days Sales Outstanding for the three months ended in Dec. 2024 was 75.80.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ahn-Gook Pharmaceutical Co's liquidation value for the three months ended in Dec. 2024 was ₩-41,676 Mil.


Ahn-Gook Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Ahn-Gook Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ahn-Gook Pharmaceutical Co Change In Receivables Chart

Ahn-Gook Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,939.85 -10,171.00 -11,980.21 -7,971.94 3,540.86

Ahn-Gook Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,787.18 -4,260.00 317.44 8,358.44 -875.03

Ahn-Gook Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,541 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ahn-Gook Pharmaceutical Co  (XKRX:001540) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Ahn-Gook Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=58722.087/70692.528*91
=75.80

2. In Ben Graham's calculation of liquidation value, Ahn-Gook Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Ahn-Gook Pharmaceutical Co's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=29738.376-137791.875+0.75 * 58722.087+0.5 * 44671.99
=-41,676

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ahn-Gook Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Ahn-Gook Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Ahn-Gook Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
993-75, Daerim-Dong, Yeongdeungpo-Gu, Seoul, KOR, 150-072
Ahn-Gook Pharmaceutical Co Ltd manufactures and markets medicines. The company is famous for medicine for ophthalmology. The company also engages in various prescription medicines.

Ahn-Gook Pharmaceutical Co Headlines

No Headlines